Vitiligo is a skin condition characterized by acquired complete epidermal depigmentation areas, it is the most common acquired hypomélanoses. This is a pathology, cosmopolitan, which affects about 1.5 to 2% of the world population, regardless of gender or ethnic origin [1].
Vitiligo usually starts in childhood or in young adults, about half to a third party develops the disease at age 20 and about 25% of them develops within 8 years with a mean age of onset between 4 and 5 years [2]. Vitiligo may also be hereditary, in fact, 20 to 30% of sufferers have a family member with the disease [3]. The controversy regarding its pathogenesis is still valid, several theories are used the most discussed of which are: autoimmune, neurogenic, autotoxique and oxidative stress. In its evolution, vitiligo may be associated with certain autoimmune diseases, including thyroid diseases, diabetes mellitus and may affect social life.
View Full Article: HERE
Go through the Journal: http://www.enlivenarchive.org/clinical-dermatology
Contact Us: dermatology@enlivenarchive.org
